glp 1 drug classification Indications for GLP-1/GIP RA Summary Sheet and Beyond! WIth multiple GLP-1 medications on
Description
Long-Term Safety Considerations As a relatively new class of medications, the long-term safety profile of GLP-1 agonists is still under evaluation
doi: 10.1210/en.2017-00461 97 LigumskyHWolfIIsraeliSHaimsohnMFerberSKarasikAet al
0.8% for non-GLP-1 RA over 36 months and had a hazard ratio (HR) of 7.64 (95% CI, 2.21-26.36
Huang Y
Synergistic (combined effect exceeds the sum)
